M&A / Deals GBL joins CVC in 10.7bn takeover bid for Recordati PharmaphorumA consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.Read full story pharminent May 22, 2026 (Last updated: May 22, 2026) Pharmaphorum A consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gilead Sciences completes Tubulis acquisition for $5bnNext: Gilead inks $140M API supply deal, tightening ties to Korean manufacturer Related Stories M&A / Deals Sky-high Parabilis, Kailera IPOs spur optimism–but only for derisked biotechs pharminent June 11, 2026 M&A / Deals Aditxt and Ignite announce merger plans with strategic partner pharminent June 10, 2026 M&A / Deals Cancer biotech Parabilis books record IPO, raising $670m pharminent June 10, 2026
